SV Health Investors Forms $90M Medtech Convergence Fund

SV Health Investors announced today that it has formed the Medtech Convergence Fund (MCF), a $90 million early-stage, medtech venture-capital fund. SV has partnered with the senior members of another Boston-based VC firm, Norwich Ventures, to create this new fund and build the portfolio. The MCF team will leverage their decades of operating and investment experience to provide entrepreneurs with the financial support and strategic guidance necessary for building a successful business. Teijin will share employees with the fund to strengthen long-term collaboration aimed at the development of healthcare businesses in international markets. In addition, through participation in company incubation activities with its new partners, Teijin aims to stimulate its own research and development of medical devices and services based on novel innovation models.